Literature DB >> 12527506

[HBsAg uptake into human trophoblasts cultured in vitro].

Xue-ping Wang1, De-zhong Xu, Yuan-gui Li, Yong-ping Yan, Ke Men, Jing-xia Zhang.   

Abstract

OBJECTIVE: To detect the entry of HBsAg into human trophoblasts cultured in vitro, to provide some clues for the mechanism responsible for HBV intrauterine transmission.
METHODS: Digestion with both trypsin (0.25%) and Dnase I(0.15 U/ml) followed by repeated purification was performed to obtain a homogeneous population of trophoblast cells. The well-developed cells during longitudinal phase were randomly divided in 6 groups, which were co-incubated respectively with HBsAg-anti-HBs complex (I), co-culture of heat-inactivated sera positive for HBsAg, HBeAg, and anti-HBc and sera with high titer anti-HBs(II), heat-inactivated sera positive for HBsAg, HBeAg, and anti-HBc(III), HBsAg (IV), heat-inactivated normal sera (V), and normal medium(VI). The coverglasses mounted with confluent cells were harvested for anti-HBs immunohistochemical staining.
RESULTS: The isolated cells comprised a highly purified villous trophoblast population and could meet the demands of further experiments. After co-incubation of the cells with different agents, HBsAg test yielded positive results in the cells co-incubated with the HBsAg-anti-HBs complex and in the co-cultures of heat-inactivated sera positive for HBsAg, HBeAg and anti-HBc with sera containing high-titer anti-HBs. HBsAg test was negative in all other cell groups.
CONCLUSION: Human trophoblast cells could take in HBsAg in the form of HBsAg-anti-HBs complex instead of single HBsAg molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527506

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  1 in total

1.  Expression of HBsAg and HBcAg in the ovaries and ova of patients with chronic hepatitis B.

Authors:  Feng Ye; Ya-Fei Yue; Shu-Hong Li; Tian-Yan Chen; Shu-Ling Zhang; Gui-Qin Bai; Min Liu
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.